Biotech Blueprint
Subscribe
Sign in
Share this post
Biotech Blueprint
KalVista’s FDA Win, Merck’s $10B Deal, and CRISPR Momentum — This Week in Biotech #60
Copy link
Facebook
Email
Notes
More
KalVista’s FDA Win, Merck’s $10B Deal, and…
Jul 11
3
Share this post
Biotech Blueprint
KalVista’s FDA Win, Merck’s $10B Deal, and CRISPR Momentum — This Week in Biotech #60
Copy link
Facebook
Email
Notes
More
FDA nods, big M&A, and major trial wins (July 3–10, 2025).
Read →
Comments
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
KalVista’s FDA Win, Merck’s $10B Deal, and…
Share this post
FDA nods, big M&A, and major trial wins (July 3–10, 2025).